Smoking habits and attitudes in a methadone maintenance treatment population
Smoking habits and attitudes in a methadone maintenance treatment population
复制标题
DOI：
10.1016/s0376-8716(96)01331-2
复制
发表时间：
1997-03-14
影响因子：
4.2
通讯作者：
Stitzer, M
中科院分区：
文献类型：
--
作者：
Clemmey, P;Brooner, R;Stitzer, M
本研究的特点是吸烟习惯和态度的美沙酮维持治疗（MMT）患者的棉被，注意种族和性别差异。在调查的179例患者中，92%（n = 165）为当前吸烟者。这些患者平均每天吸烟24.8支。开始吸烟的平均年龄为13.6岁，53%的椋鸟年龄在13岁或以下。平均Fagerstrom耐受性问卷（FTQ）评分为7.5。与白人相比，黑人每天吸烟较少（21.6 vs 27.5），过期CO水平较低（18.8 vs 21.6 ppm），但尿可替宁水平较高（1812 vs 1419 ng/ml），并且更可能吸烟薄荷醇香烟（95 vs 46%）。女性在尼古丁依赖的FTQ测量中得分高于男性（8.0比7.2），在戒烟自我效能的测量中低于男性。样本中的受试者作为一个整体都很清楚吸烟的健康风险，这一点可以从健康风险认知问题的高分中看出。61%（= 110）的受试者计划在未来6个月内戒烟，57%的受试者对现场戒烟计划“非常感兴趣”，80%的受试者表示有兴趣使用尼古丁替代产品。总体而言，这些结果表明MMT患者的吸烟率较高，证实了药物滥用人群中吸烟习惯种族差异的既往发现，并表明MMT患者对戒烟和使用尼古丁替代产品感兴趣。这些数据支持在方便接触患者和密切监测进展的环境中对这一人群实施戒烟治疗的可行性。(C)1997 Elsevier Science爱尔兰有限公司
This study characterized smoking habits and attitudes about quilting in methadone maintenance treatment (MMT) patients, with attention to race and gender differences. Of 179 patients surveyed, 92% (n = 165) were current smokers. These patients reported smoking a mean of 24.8 cigarettes per day. Mean age at smoking initiation was 13.6 years with 53% starling at age 13 or younger. The mean Fagerstrom tolerance questionnaire (FTQ) score was 7.5. Blacks as compared to Whites smoked fewer cigarettes per day (21.6 versus 27.5), had lower expired CO levels (18.8 versus 21.6 ppm), but higher urinary cotinine levels (1812 versus 1419 ng/ml) and were more likely to smoke menthol cigarettes (95 versus 46%). Females scored higher than males on the FTQ measure of nicotine dependence (8.0 versus 7.2), and lower than males on a measure of quit smoking self-efficacy. Subjects in the sample as a whole were well aware of health risks of smoking, as indicated by high scores on health risk perception questions. Sixty-one percent (it = 110) of subjects planned to quit within the next 6 months, 57% were 'very interested' in an on-site quit smoking program and 80% expressed interest in using nicotine replacement products. Overall, these results indicate high rates of smoking in MMT patients, confirm within a drug abusing population prior findings of racial differences in smoking habits, and suggest that MMT patients are interested in quitting and in using nicotine replacement products. The data support feasibility of implementing smoking cessation treatments with this population in a setting that allows for convenient access to patients and close monitoring of progress. (C) 1997 Elsevier Science Ireland Ltd.